Literature DB >> 25560528

Reporting patterns of adverse drug reactions over recent years in China: analysis from publications.

Xiao-jing Guo1, Xiao-fei Ye, Xing-xing Wang, Jing Wang, Wen-tao Shi, Qing-bin Gao, Tian-yi Zhang, Jin-fang Xu, Tian-tian Zhu, Jia He.   

Abstract

PURPOSE: The goal of this study was to clarify the reporting patterns of self-reported adverse drug reactions (ADRs) in China.
METHODS: A variety of sources were searched, including the official website of China FDA, the national center for ADR monitoring center, publications from PubMed, and so on. We retrieved the relevant information and made descriptive and comparative analysis from the year 2009 to 2013.
RESULTS: The ADR reporting numbers were 638,996, 692,904, 852,799, 1,200,000 and 1,317,000 from 2009 to 2013, respectively. Healthcare professionals contributed significantly, and their proportion always exceeded 80% before 2012. The average report per million inhabitants has increased from 479 to 983 from 2009 to 2013. However, the proportion of new or serious report was always below 25%. The reports mainly concern anti-infective agents and traditional Chinese medicine (TCM), especially TCM injection. The proportion of ADR reports in geriatric patients has increased for 4 consecutive years.
CONCLUSIONS: ADR report numbers and reporting rates in China are on the rise. However, the proportion of new or serious reports as well as the proportion of reports contributed by consumers and pharmaceutical companies are still quite low. More attention should be paid to the elderly, anti-infective agents and TCM, especially TCM injections.

Entities:  

Keywords:  China; pharmacovigilance; reporting pattern; self-reported adverse drug reaction

Mesh:

Substances:

Year:  2015        PMID: 25560528     DOI: 10.1517/14740338.2015.985647

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  8 in total

1.  Signal Detection Based on Time to Onset Algorithm in Spontaneous Reporting System of China.

Authors:  Tianyi Zhang; Xiaofei Ye; Xiaojing Guo; Guizhi Wu; Yongfang Hou; Jinfang Xu; Wentao Shi; Tiantian Zhu; Yuan Zhang; Xinji Zhang; Jiaqi Song; Jia He
Journal:  Drug Saf       Date:  2017-04       Impact factor: 5.606

Review 2.  Worldwide Occurrence and Investigations of Contamination of Herbal Medicines by Tropane Alkaloids.

Authors:  Thomas Y K Chan
Journal:  Toxins (Basel)       Date:  2017-09-15       Impact factor: 4.546

3.  Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.

Authors:  Chunxiao Li; Tao Xu; Peng Zhou; Junhua Zhang; Ge Guan; Hui Zhang; Xiao Ling; Weixia Li; Fei Meng; Guanping Liu; Linyan Lv; Jun Yuan; Xuelin Li; Mingjun Zhu
Journal:  BMC Complement Altern Med       Date:  2018-10-16       Impact factor: 3.659

4.  The severity of adverse drug reactions and their influencing factors based on the ADR monitoring center of Henan Province.

Authors:  Ziqi Yan; Zhanchun Feng; Zhiming Jiao; Chaoyi Chen; Ganyi Wang; Da Feng
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

5.  Safety of Using Traditional Chinese Medicine Injections in Primary Medical Institutions: Based on the Spontaneous Reporting System 2016-2020 in Henan Province, China.

Authors:  Ziqi Yan; Zhanchun Feng; Zhiming Jiao; Ganyi Wang; Chaoyi Chen; Da Feng
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

6.  Automatic assessment of adverse drug reaction reports with interactive visual exploration.

Authors:  Zongyang Gao; Yu Yang; Ruogu Meng; Jinyang Yu; Liang Zhou
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

7.  Chromatographic fingerprints analysis and determination of seven components in Danmu preparations by HPLC-DAD/QTOF-MS.

Authors:  Nanxin Li; Jinju Zhang; Ying Zhang; Zhiguo Ma; Jinhong Liao; Hui Cao; Menghua Wu
Journal:  Chin Med       Date:  2020-02-18       Impact factor: 5.455

8.  Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase.

Authors:  Florence van Hunsel; Sonja van de Koppel; Souad Skalli; Andrea Kuemmerle; Lida Teng; Jia-Bo Wang; Joanne Barnes
Journal:  Front Pharmacol       Date:  2019-11-06       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.